317.84 -3.55 (-1.10%)

692.4K XNYS Volume

XNYS 21 Mar, 2025 11:49 AM (EDT)

Cigna Group (The) Key Metrics

Select
All financials are in USD Million and price data in USD
VIEW MORE
Medium Financial Strength
38.9 / 100
Mid Valuation
45.7 / 100
Technically Neutral
51.7 / 100
Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM

Cigna Group (The) Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '26150k200k250k300kActual RevenueAvg. Estimate
Hit

Cigna Group (The)'s Revenue was higher than average estimate 2 times in past 3 years

EPS forecast

Current EPS
12.1
Avg. Estimate
24.1
Low Estimate
22.1
High Estimate
25
Current EPS
Avg. Estimate
Hit

EPS is expected to grow by 98.6% in FY25

Consensus Recommendation

25 ANALYST Recommendations
BUY

Created with Highcharts 7.2.26Hold6Buy13Strong Buy

The consensus recommendation from 25 analysts for Cigna Group (The) is BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Cigna Group (The) Stock Analysis

Cigna Group (The) stock analysis with key metrics, changes, and trends.

Cigna Group (The) MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$244,384 M25.21%positive

Annual Revenue rose 25.21%, in the last year to $244,384 M. Its sector's average revenue growth for the last fiscal year was 7.94%.

Annual Net Profit$3,434 M33.5%negative

Annual Net Profit fell 33.5% in the last year to $3,434 M. Its sector's average net profit growth for the last fiscal year was 2.84%.

Price to Earning Ratio25.09-negative

Price to Earning Ratio is 25.09, higher than its sector PE ratio of 24.32.

Stock Price$317.84-10.17%negative

Stock Price fell 10.17% and underperformed its sector by 11.21% in the past year.

Quarterly Revenue$65,717 M28.66%positive

Quarterly Revenue rose 28.66% YoY to $65,717 M. Its sector's average revenue growth YoY for the quarter was 9.31%.

Quarterly Net profit$1,424 M38.39%positive

Quarterly Net profit rose 38.39% YoY to $1,424 M. Its sector's average net profit growth YoY for the quarter was 37.53%.

Debt to Equity Ratio0.78-positive

Debt to Equity Ratio of 0.78 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)7.87 %7.87%negative

Return on Equity(ROE) for the last financial year was 7.87%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding173.44 %0.18%positive

Mutual Fund Holding increased by 0.18% in the last quarter to 173.44.

Promoter Share Holding0.12 %-0.05%negative

Promoter Share Holding decreased by 0.05% in the most recent quarter to 0.12%.

Interest Coverage Ratio4.67-positive

Interest Coverage Ratio is 4.67, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding89.84 %0%neutral

Institutional Holding remained the same in the last quarter at 89.84%.

VIEW LESS


Loading data..

Cigna Group (The) - Company Profile

What does Cigna Group (The) do?

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of September 2024.

Cigna Group (The) Management structure

All Gross Remunerations are in USD
Ms. Ann M. Dennison
Deputy Chief Financial Officer
-
2025
Gross Remuneration
Year
Mr. Brian C. Evanko
Executive Vice President, Chief Financial Officer, President and Chief Executive Officer, Cigna Healthcare
-
2025
Gross Remuneration
Year

Cigna Group (The) Board of directors

All Gross Remunerations are in USD
Mr. Eric C. Wiseman
Lead Independent Director
372.78 K
2024
Gross Remuneration
Year
Ms. Donna F. Zarcone
Independent Director
337.78 K
2024
Gross Remuneration
Year
Ms. Kimberly A. Ross
Independent Director
337.78 K
2024
Gross Remuneration
Year
Mr. Eric J. Foss
Independent Director
335.28 K
2024
Gross Remuneration
Year
Dr. Elder Granger, M.D.
Independent Director
335.28 K
2024
Gross Remuneration
Year
Ms. Kathleen M. Mazzarella
Independent Director
335.28 K
2024
Gross Remuneration
Year

Cigna Group (The) FAQ

How is Cigna Group (The) today?
Cigna Group (The) today is trading in the red, and is down by -1.10% at 317.84.
Cigna Group (The) is currently trading down -1.10% on an intraday basis. In the past week the stock rose 1.88%. stock has been up 14.78% in the past quarter and fell -10.17% in the past year. You can view this in the overview section.